<?xml version="1.0" encoding="UTF-8"?>
<p id="Par18">Using approximate Bayesian computation
 <sup>
  <xref ref-type="bibr" rid="CR38">38</xref>,
  <xref ref-type="bibr" rid="CR39">39</xref>
 </sup>, we fit a deterministic compartmental susceptible-exposed-symptomatic-recovered (SEYR) model
 <sup>
  <xref ref-type="bibr" rid="CR43">43</xref>
 </sup> to incidence time series for the 2016–2017, 2017–2018, and 2018–2019 influenza seasons in the United States to estimate seasonal transmission parameters (Table 
 <xref rid="Tab1" ref-type="table">1</xref> and Supplementary Table 
 <xref rid="MOESM1" ref-type="media">3</xref>). Following refs. 
 <sup>
  <xref ref-type="bibr" rid="CR44">44</xref>,
  <xref ref-type="bibr" rid="CR45">45</xref>
 </sup>, flu incidence is estimated as the product of CDC-reported ILINet activity and WHO lab percent positive influenza tests
 <sup>
  <xref ref-type="bibr" rid="CR12">12</xref>,
  <xref ref-type="bibr" rid="CR13">13</xref>
 </sup>. We then incorporated viral replication dynamics and antiviral treatment into a stochastic agent-based version of the fitted SEYR model (Supplementary Section 
 <xref rid="MOESM1" ref-type="media">3</xref>). We replace the discrete exposed and symptomatic states with continuously changing infectiousness from the moment of infection that is governed by our within-host model. Exposed individuals become symptomatic (and thus eligible for treatment) according to 
 <italic>L</italic>; treated cases obtain their first dose within a 48 h window following distribution 
 <italic>G</italic>
 <sub>0–48</sub> (unless otherwise specified); symptomatic recover when their virus load falls below zero yielding average infectious periods of 9, 4, and 7 days, as infection for untreated, baloxavir-treated, and oseltamivir-treated cases, respectively (assuming treatment times follow 
 <italic>G</italic>
 <sub>0–48</sub>). The force of infection (the probability that a susceptible individual becomes exposed) is given by 
 <inline-formula id="IEq5">
  <alternatives>
   <tex-math id="M9">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\lambda = \frac{{\mathop {\sum }\nolimits_{j \in Y\mathop { \cup }\nolimits^ T}^{} \beta _j(t)}}{N}$$\end{document}</tex-math>
   <math id="M10">
    <mi>λ</mi>
    <mo>=</mo>
    <mfrac>
     <mrow>
      <msubsup>
       <mrow>
        <mo>∑</mo>
       </mrow>
       <mrow>
        <mi>j</mi>
        <mo>∈</mo>
        <mi>Y</mi>
        <msup>
         <mrow>
          <mo>∪</mo>
         </mrow>
         <mrow>
          <mi>T</mi>
         </mrow>
        </msup>
       </mrow>
       <mrow/>
      </msubsup>
      <msub>
       <mrow>
        <mi>β</mi>
       </mrow>
       <mrow>
        <mi>j</mi>
       </mrow>
      </msub>
      <mrow>
       <mo>(</mo>
       <mrow>
        <mi>t</mi>
       </mrow>
       <mo>)</mo>
      </mrow>
     </mrow>
     <mrow>
      <mi>N</mi>
     </mrow>
    </mfrac>
   </math>
   <inline-graphic xlink:href="41467_2020_16585_Article_IEq5.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </alternatives>
 </inline-formula>, where 
 <italic>N</italic> is the population size and 
 <italic>β</italic>
 <sub>
  <italic>j</italic>
 </sub>(
 <italic>t</italic>) is the transmission rate of the 
 <italic>j</italic>th infectious individual (symptomatic or treated) at time 
 <italic>t</italic>, which is determined by the product of a population-wide scaling factor 
 <italic>Φ</italic> estimated from seasonal influenza incidence data and the individual’s infectiousness at time 
 <italic>t</italic> based on the within-host viral load model. Supplementary Section 
 <xref rid="MOESM1" ref-type="media">6</xref> addresses the assumptions and robustness of the model with respect to influenza virus type.
</p>
